Please login to the form below

Not currently logged in
Email:
Password:

financial results 2012

This page shows the latest financial results 2012 news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs OTC use of Sanofi's allergy drug

FDA panel backs OTC use of Sanofi's allergy drug

Profits have declined since 2008, however, when Teva and Barr Pharmaceuticals won a patient challenge to launch their own generic copy, and Nasacort AQ achieved revenues of just 71m during 2012 ... This is part of a wider plan to build its consumer

Latest news

More from news
Approximately 17 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics